Related Experiment Video

Updated: May 24, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Targeting opioidergic pathways as a novel biological treatment for advanced pancreatic cancer

Ian S Zagon, Patricia J McLaughlin

    Expert Review of Gastroenterology & Hepatology
    |March 2, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
    06:21

    Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

    Published on: November 19, 2019

    Related Experiment Videos

    Last Updated: May 24, 2026

    Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
    07:08

    Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

    Published on: February 2, 2024

    Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
    06:21

    Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

    Published on: November 19, 2019

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Chronic Pancreatitis II: Collaborative Care01:29

    Chronic Pancreatitis II: Collaborative Care

    The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
    Assessment:

    Articles linked to this work by shared authors, journal, and citation graph.

    Mitigation of Oxidative Stress Pathways in the Diabetic Cornea and Lacrimal Glands Contributes to the Rapid Reversal of Diabetic Dry Eye by Naltrexone.

    Investigative ophthalmology & visual science·2026

    A Phase I Study of the Naturally Occurring Bioactive, Opioid Growth Factor, in Patients with Unresectable Hepatocellular Cancer.

    Cancer investigation·2025

    Exploring the relationships of physical, mental, and emotional symptoms and serum biomarkers of angiogenesis in multiple sclerosis.

    Multiple sclerosis journal - experimental, translational and clinical·2025

    Reversal of Diabetic Dry Eye by Topical Opioid Receptor Blockade Follows Dual Pathways.

    Investigative ophthalmology & visual science·2025

    Topical naltrexone increases aquaporin 5 production in the lacrimal gland and restores tear production in diabetic rats.

    Experimental biology and medicine (Maywood, N.J.)·2024

    Safety study of topical naltrexone therapy for diabetic skin wounds is confirmed in Göttingen mini-pigs.

    Drug development research·2023

    Recent developments in the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.

    Expert review of gastroenterology & hepatology·2026

    Helicobacter pylori eradication and gastric cancer prevention: current evidence and future perspectives.

    Expert review of gastroenterology & hepatology·2026

    Preoperative biliary drainage in resectable perihilar cholangiocarcinoma: real-world burden.

    Expert review of gastroenterology & hepatology·2026

    Screening strategies for colorectal cancer: adjusting for individual risk factors.

    Expert review of gastroenterology & hepatology·2026

    IPMN beyond the cyst: toward a broader framework of pancreatic and systemic cancer susceptibility.

    Expert review of gastroenterology & hepatology·2026

    Food-based enteral formulas in pediatric clinical practice: an expert opinion.

    Expert review of gastroenterology & hepatology·2026

    Integrating a Tumor Size-Overall Survival Model Into a Spatial Quantitative Systems Pharmacology Framework for Antibody-Drug Conjugates in Non-Small Cell Lung Cancer.

    CPT: pharmacometrics & systems pharmacology·2026

    The Future of all-Comers Trials in the Era of Precision Oncology.

    Clinical pharmacology and therapeutics·2026

    Tumor Treating Fields Enhance Temozolomide-Associated Growth Suppression in Glioblastoma Cells and Patient-Derived Organoids Through Cell-Cycle Blockade, Apoptosis, and SMAD-Associated Signaling.

    CNS neuroscience & therapeutics·2026

    MyoD and Myogenin regulatory cascade is targeted by tumor signals to repress myogenesis in cancer cachexia.

    The Biochemical journal·2026

    Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus).

    Journal of Alzheimer's disease : JAD·2026

    Conferone: Sources, Anticancer Mechanisms, and Potential in Overcoming Chemoresistance - A Comprehensive Review.

    Current pharmaceutical design·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us